| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | White to off-white powder | Conforms |
| Assay by HPLC | ≥99.0% | 99.7% |
| Water | ≤0.5% | 0.05% |
| Benzene | ≤100PPM | 18.4PPM |
| Any Individual Impurity | ≤0.10% | 0.09% |
| Total Impurity | ≤1.0% | 0.3% |
| Conclusion | Conforms to Factory Standard | |
We are professional 2-(3-Benzoylphenyl)propionitrile manufacturer and 3-Benzoyl-α-methylphenylacetonitrile supplier in China, We offer quality 3-(1-Cyanoethyl)benzophenone you can fully trust, also we have India factory and producer of 3-(1-Cyanoethyl)benzophenone,Pls send inquiry of 3-(1-Cyanoethyl)benzophenone CAS:42872-30-0 to info@nbinno.com if you have any interests, thank you!
Related News: In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.3-cloro-1- (4-octilfenil) propan-1-ona CAS:928165-59-7 The man recently traveled to Wuhan, China, and sought medical care soon after his return to Massachusetts.3-Amino-2-Chlor-6-Methylphenol According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.302-72-7 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.
